Filing Details
- Accession Number:
- 0001127602-21-023064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 16:25:07
- Reporting Period:
- 2021-08-02
- Accepted Time:
- 2021-08-04 16:25:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1216055 | N Marc Casper | 168 Third Avenue Waltham MA 02451 | Chairman & Ceo | Yes | Yes | No | No |
Transaction Summary
Sold: | 20,000 shares | Avg. Price: $535.59 | Total Value: $10,711,859.50 |
Number of Shares After Transactions: | 209,060 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-05-20 | 325 | $0.00 | 229,060 | No | 5 | G | Direct | |
Common Stock | Acquisiton | 2021-05-20 | 325 | $0.00 | 34,825 | No | 5 | G | Indirect | By Marc N. Casper 2020 Irrevocable Trust |
Common Stock | Disposition | 2021-06-14 | 2,000 | $0.00 | 0 | No | 5 | G | Indirect | By Spouse |
Common Stock | Acquisiton | 2021-06-14 | 2,000 | $0.00 | 2,000 | No | 5 | G | Indirect | By Alison Casper 2020 Irrevocable Trust |
Common Stock | Disposition | 2021-08-02 | 1,817 | $533.31 | 227,243 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 3,413 | $534.12 | 223,830 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 1,431 | $535.06 | 222,399 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 860 | $536.62 | 221,539 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 1,779 | $537.69 | 219,760 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 200 | $538.94 | 219,560 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 200 | $540.85 | 219,360 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 200 | $542.92 | 219,160 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 100 | $543.52 | 219,060 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-03 | 741 | $533.05 | 218,319 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-03 | 1,110 | $534.65 | 217,209 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-03 | 3,441 | $535.41 | 213,768 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-03 | 4,296 | $536.51 | 209,472 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-03 | 412 | $537.94 | 209,060 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 5 | G | Indirect | By Marc N. Casper 2020 Irrevocable Trust |
No | 5 | G | Indirect | By Spouse |
No | 5 | G | Indirect | By Alison Casper 2020 Irrevocable Trust |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 54,330 | Indirect | By Marc N. Casper 2012 Irrevocable Trust |
Footnotes
- Gift of securities by the reporting person to an irrevocable trust for the benefit of his children.
- Gift of securities by the reporting person's spouse to an irrevocable trust for the benefit of the spouse's children. The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.66 to $533.64, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14), (15) and (16) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.69 to $534.68, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.70 to $535.69, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.01 to $536.98, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.15 to $538.00, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $538.64 to $539.23, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.63 to $541.07, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $542.47 to $543.37, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $532.55 to $533.51, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.97 to $534.92, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.97 to $535.91, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.04 to $536.98, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.35 to $538.255, inclusive.